A neuron-specific Isca1 knockout rat developments multiple mitochondrial dysfunction syndromes

Hanxuan Sheng1, Dan Lu2, Xiaolong Qi2

  • 1Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Abstract

Insights

Researchers developed a novel rat model for Multiple Mitochondrial Dysfunction Syndromes (MMDS) by knocking out Isca1 in neurons. This model exhibits key disease features, offering new avenues for studying MMDS pathogenesis and potential treatments.

Area of Science:

  • Neuroscience
  • Mitochondrial Biology
  • Genetics

Background:

  • Multiple Mitochondrial Dysfunction Syndromes (MMDS) are rare genetic disorders affecting mitochondrial iron-sulfur cluster synthesis.
  • Mutations in these proteins lead to severe neurological impairment.

Purpose of the Study:

  • To establish a novel rat model for MMDS type 5 (MMDS5) specifically in the nervous system.
  • To investigate the pathological mechanisms and neuronal death associated with Isca1 deficiency.

Main Methods:

  • Generated neuron-specific Isca1 knockout rats using CRISPR-Cas9 technology.
  • Assessed brain structure via MRI, behavioral abnormalities through various tests, and neuronal pathology via histological staining.
  • Analyzed mitochondrial damage using TEM, western blot, and ATP assays.

Main Results:

  • Successfully modeled MMDS5 in the rat nervous system, observing developmental delays, epilepsy, and memory deficits.
  • Confirmed massive neuronal death, reduced Nissl bodies and dendritic spines, and significant mitochondrial damage (fragmentation, cristae fracture).
  • Observed reduced respiratory chain complex protein content and ATP production, leading to neuronal oncosis.

Conclusions:

  • The developed rat model is valuable for studying MMDS pathogenesis.
  • The model's extended survival (up to 8 weeks) provides a crucial window for clinical treatment research.
  • This model holds potential for investigating treatments for neurological symptoms in various mitochondrial diseases.